Lagahit, Mia Nichole .
HRN: 19-34-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2025
CEFUROXIME 750MG (VIAL)
12/13/2025
12/20/2025
IV
400mg
Q8hours
UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes